This limited competition grant from the Alzheimer’s Disease Cooperative Study (ADCS) is specifically for the renewal of the ADCS, which serves as the pre-eminent Alzheimer’s disease (AD) clinical trials consortium. This grant is for the purpose of continuing to advance crucial research in the development of interventions aimed at treating, delaying the progression of, or preventing AD. A key focus will be on exploring and developing interventions that might not be readily pursued or developed by the pharmaceutical industry. The renewed consortium will maintain its leadership in conducting innovative clinical trials and collaborative studies, thereby accelerating the discovery and testing of novel therapies and significantly contributing to global efforts against Alzheimer’s disease.
Opportunity ID: 131973
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AG-13-001 |
| Funding Opportunity Title: | Limited Competition: Alzheimer’s Disease Cooperative Study (U19) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.866 — Aging Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 28, 2011 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Mar 07, 2012 |
| Current Closing Date for Applications: | Mar 07, 2012 |
| Archive Date: | Apr 07, 2012 |
| Estimated Total Program Funding: | $13,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This limited competition FOA is to continue the Alzheimer’s Disease Cooperative Study (ADCS) as the pre-eminent Alzheimer’s disease (AD) clinical trials consortium. The purpose of this FOA is to solicit the renewal application for the next 5-year cycle of the ADCS. The goals of this next phase are to continue to advance research in the development of interventions that might be useful for treating, delaying, or preventing AD, particularly interventions that might not be developed by industry. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-13-001.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
There are no packages on this grant.
Share This Post, Choose Your Platform!
About the Author: osnqt
